These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20727346)

  • 61. The effect of pH on beta(2) adrenoceptor function. Evidence for protonation-dependent activation.
    Ghanouni P; Schambye H; Seifert R; Lee TW; Rasmussen SG; Gether U; Kobilka BK
    J Biol Chem; 2000 Feb; 275(5):3121-7. PubMed ID: 10652295
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predicting novel binding modes of agonists to β adrenergic receptors using all-atom molecular dynamics simulations.
    Vanni S; Neri M; Tavernelli I; Rothlisberger U
    PLoS Comput Biol; 2011 Jan; 7(1):e1001053. PubMed ID: 21253557
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of ligands on the equilibria between functional states of a G protein-coupled receptor.
    Kim TH; Chung KY; Manglik A; Hansen AL; Dror RO; Mildorf TJ; Shaw DE; Kobilka BK; Prosser RS
    J Am Chem Soc; 2013 Jun; 135(25):9465-74. PubMed ID: 23721409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Receptor binding thermodynamics at the neuronal nicotinic receptor.
    Borea PA; Varani K; Gessi S; Merighi S; Dal Piaz A; Gilli P; Gilli G
    Curr Top Med Chem; 2004; 4(3):361-8. PubMed ID: 14754451
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determinants of Neutral Antagonism and Inverse Agonism in the β
    Calderón JC; Ibrahim P; Gobbo D; Gervasio FL; Clark T
    J Chem Inf Model; 2024 Mar; 64(6):2045-2057. PubMed ID: 38447156
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor.
    Moukhametzianov R; Warne T; Edwards PC; Serrano-Vega MJ; Leslie AG; Tate CG; Schertler GF
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8228-32. PubMed ID: 21540331
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multiple signaling states of G-protein-coupled receptors.
    Perez DM; Karnik SS
    Pharmacol Rev; 2005 Jun; 57(2):147-61. PubMed ID: 15914464
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Marcus treatment of rate constants for protonation of ring-substituted alpha-methoxystyrenes: intrinsic reaction barriers and the shape of the reaction coordinate.
    Richard JP; Williams KB
    J Am Chem Soc; 2007 May; 129(21):6952-61. PubMed ID: 17488079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.
    Strange PG
    Br J Pharmacol; 2008 Apr; 153(7):1353-63. PubMed ID: 18223670
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Agonists in the Extended Conformation Stabilize the Active State of β-Adrenoceptors.
    Efimov AV; Meshcheryakova OV; Ryazanov AG
    Biochemistry (Mosc); 2022 Jul; 87(7):628-639. PubMed ID: 36154885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathway and mechanism of drug binding to G-protein-coupled receptors.
    Dror RO; Pan AC; Arlow DH; Borhani DW; Maragakis P; Shan Y; Xu H; Shaw DE
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13118-23. PubMed ID: 21778406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of primary and secondary protein structure in neurotransmitter receptor activation mechanisms.
    Mercier GA; Osman R; Weinstein H
    Protein Eng; 1988 Oct; 2(4):261-70. PubMed ID: 3074305
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative antiradical activity and molecular Docking/Dynamics analysis of octopamine and norepinephrine: the role of OH groups.
    Dimić D; Milanović Ž; Jovanović G; Sretenović D; Milenković D; Marković Z; Dimitrić Marković J
    Comput Biol Chem; 2020 Feb; 84():107170. PubMed ID: 31810852
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An Artificial Receptor for Dimethyl Aspartate.
    Mizutani T; Murakami T; Kurahashi T; Ogoshi H
    J Org Chem; 1996 Jan; 61(2):539-548. PubMed ID: 11666973
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clarifying intrinsic efficacy, partial agonism, and full agonism: moving beyond efficacy and affinity towards ligand-directed signalling. Comment on Br J Anaesth 2024; 132: 431-2.
    Garland H
    Br J Anaesth; 2024 Jun; 132(6):1332-1333. PubMed ID: 38548530
    [No Abstract]   [Full Text] [Related]  

  • 76. Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor.
    Bock A; Chirinda B; Krebs F; Messerer R; Bätz J; Muth M; Dallanoce C; Klingenthal D; Tränkle C; Hoffmann C; De Amici M; Holzgrabe U; Kostenis E; Mohr K
    Nat Chem Biol; 2014 Jan; 10(1):18-20. PubMed ID: 24212135
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thermodynamic analysis of the drug-receptor interaction.
    Raffa RB; Porreca F
    Life Sci; 1989; 44(4):245-58. PubMed ID: 2536880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Concerning the thermodynamic definition and graphical manifestations of positive and negative co-operativity.
    Bardsley WG; Wyman J
    J Theor Biol; 1978 May; 72(2):373-6. PubMed ID: 661346
    [No Abstract]   [Full Text] [Related]  

  • 79. Towards a thermodynamic definition of efficacy in partial agonism: The thermodynamics of efficacy and ligand proton transfer in a G protein-coupled receptor of the rhodopsin class.
    Broadley KJ; Sykes SC; Davies RH
    Biochem Pharmacol; 2010 Nov; 80(10):1537-45. PubMed ID: 20727346
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors.
    Broadley KJ; Nederkoorn PH; Timmerman H; Timms D; Davies RH
    J Theor Biol; 2000 Jul; 205(2):297-320. PubMed ID: 10873440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.